C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.

"Declarations Ethics approval and consent to participateThe study was conducted in accordance with the Declaration of Helsinki and the Good Scientific Practice statements of the participating institutions. Moreover, study approval was provided by the institutional Ethics Committees (Medical University of Vienna EK#: 2196/2019; National Koranyi Institute of Pulmonology ETT-TUKEB 23636–2/2018, 23636/10/2018/EÜIG). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding Open access funding provided by Semmelweis University. BD was supported by the Austrian Science Fund (FWF I3522, FWF I3977, and I4677) and the “BIOSMALL” EU HORIZON-MSCA-2022-SE-01 project. BD and ZM were supported by funding from the Hungarian National Research, Development, and Innovation Office (TKP2021‐EGA‐33, 2020‐1.1.6‐JÖVŐ, FK‐143751, and FK-147045). ZM was supported by the New National Excellence Program of the Ministry for Innovation and Technology of Hungary (UNKP‐20‐3, UNKP‐21‐3 and UNKP-23–5), and by the Bolyai Research Scholarship of the Hungarian Academy of Sciences. ZM is also the recipient of an International Association for the Study of Lung Cancer/International Lung Cancer Foundation Young Investigator Grant (2022). BF is a recipient of the Semmelweis 250 + Excellence PhD Scholarship (EFOP-3.6.3-VEKOP-16–2017- 00009) of the Semmelweis University. VL is a recipient of the Bolyai Research Scholarship of the Hungarian Academy of Sciences and the UNKP-19–4 New National Excellence Program of the Ministry for Innovation and Technology. KS was supported by the Austrian Science Fund (FWF No. T 1062-B33) and the City of Vienna Fund for Innovative Interdisciplinary Cancer Research."